Kinnate Biopharma Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kinnate Biopharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q4 2023.
  • Kinnate Biopharma Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $3.83M, a 22.5% decline year-over-year.
  • Kinnate Biopharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $19.9M, a 1.72% increase year-over-year.
  • Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.9M, a 1.72% increase from 2022.
  • Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $19.6M, a 30.4% increase from 2021.
  • Kinnate Biopharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15M, a 506% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $19.9M $3.83M -$1.11M -22.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $21M $5.28M +$300K +6.02% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $20.7M $5.4M +$521K +10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $20.2M $5.4M +$627K +13.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $19.6M $4.94M +$640K +14.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $18.9M $4.98M +$820K +19.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $18.1M $4.88M +$1.12M +29.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $17M $4.78M +$1.98M +71% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $15M $4.3M +$3.08M +251% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $11.9M $4.16M +$3.45M +483% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $8.49M $3.76M +$3.35M +817% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $5.14M $2.79M +$2.67M +2082% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.48M $1.23M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $714K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $410K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $128K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.